These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 28892043)

  • 1. Loss of PRP4K drives anoikis resistance in part by dysregulation of epidermal growth factor receptor endosomal trafficking.
    Corkery DP; Clarke LE; Gebremeskel S; Salsman J; Pinder J; Le Page C; Meunier L; Xu Z; Mes-Masson AM; Berman JN; Johnston B; Dellaire G
    Oncogene; 2018 Jan; 37(2):174-184. PubMed ID: 28892043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen receptor alpha (ESR1)-signaling regulates the expression of the taxane-response biomarker PRP4K.
    Lahsaee S; Corkery DP; Anthes LE; Holly A; Dellaire G
    Exp Cell Res; 2016 Jan; 340(1):125-31. PubMed ID: 26712520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PRP4K is a HER2-regulated modifier of taxane sensitivity.
    Corkery DP; Le Page C; Meunier L; Provencher D; Mes-Masson AM; Dellaire G
    Cell Cycle; 2015; 14(7):1059-69. PubMed ID: 25602630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haploinsufficient tumor suppressor PRP4K is negatively regulated during epithelial-to-mesenchymal transition.
    Clarke LE; Cook A; Mathavarajah S; Bera A; Salsman J; Habib E; Van Iderstine C; Bydoun M; Lewis SM; Dellaire G
    FASEB J; 2021 Nov; 35(11):e22001. PubMed ID: 34674320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ErbB2-dependent downregulation of a pro-apoptotic protein Perp is required for oncogenic transformation of breast epithelial cells.
    Khan IA; Yoo BH; Masson O; Baron S; Corkery D; Dellaire G; Attardi LD; Rosen KV
    Oncogene; 2016 Nov; 35(44):5759-5769. PubMed ID: 27109096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curcumin induces radiosensitivity of in vitro and in vivo cancer models by modulating pre-mRNA processing factor 4 (Prp4).
    Shehzad A; Park JW; Lee J; Lee YS
    Chem Biol Interact; 2013 Nov; 206(2):394-402. PubMed ID: 24144778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serine protease inhibitor Kazal type 1 (SPINK1) drives proliferation and anoikis resistance in a subset of ovarian cancers.
    Mehner C; Oberg AL; Kalli KR; Nassar A; Hockla A; Pendlebury D; Cichon MA; Goergen KM; Maurer MJ; Goode EL; Keeney GL; Jatoi A; Sahin-Tóth M; Copland JA; Radisky DC; Radisky ES
    Oncotarget; 2015 Nov; 6(34):35737-54. PubMed ID: 26437224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tinker, Tailor, Tumour Suppressor: The Many Functions of PRP4K.
    Habib EB; Mathavarajah S; Dellaire G
    Front Genet; 2022; 13():839963. PubMed ID: 35281802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anoikis molecular pathways and its role in cancer progression.
    Paoli P; Giannoni E; Chiarugi P
    Biochim Biophys Acta; 2013 Dec; 1833(12):3481-3498. PubMed ID: 23830918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelin-1 promotes epithelial-to-mesenchymal transition in human ovarian cancer cells.
    Rosanò L; Spinella F; Di Castro V; Nicotra MR; Dedhar S; de Herreros AG; Natali PG; Bagnato A
    Cancer Res; 2005 Dec; 65(24):11649-57. PubMed ID: 16357176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of anoikis and suppression of human ovarian tumor growth in vivo by down-regulation of Bcl-X(L).
    Frankel A; Rosen K; Filmus J; Kerbel RS
    Cancer Res; 2001 Jun; 61(12):4837-41. PubMed ID: 11406560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of anoikis resistance by NADPH oxidase 4 and epidermal growth factor receptor.
    Kim H; Sung JY; Park EK; Kho S; Koo KH; Park SY; Goh SH; Jeon YK; Oh S; Park BK; Jung YK; Kim YN
    Br J Cancer; 2017 Jan; 116(3):370-381. PubMed ID: 28081539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anoikis-suppression and invasion induced by tyrosine kinase receptor B in OVCAR3 ovarian cancer cells].
    Yu XH; Yang YX; Cai B; Yan Q; He YY; Wan XP
    Zhonghua Fu Chan Ke Za Zhi; 2008 Sep; 43(9):695-9. PubMed ID: 19087522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CASC4/GOLM2 drives high grade serous carcinoma anoikis resistance through the recycling of EGFR.
    Bapat J; Yamamoto TM; Woodruff ER; Qamar L; Mikeska RG; Aird KM; Watson ZL; Brubaker LW; Bitler BG
    Cancer Gene Ther; 2024 Feb; 31(2):300-310. PubMed ID: 38030811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intestinal epithelial cancer cell anoikis resistance: EGFR-mediated sustained activation of Src overrides Fak-dependent signaling to MEK/Erk and/or PI3-K/Akt-1.
    Demers MJ; Thibodeau S; Noël D; Fujita N; Tsuruo T; Gauthier R; Arguin M; Vachon PH
    J Cell Biochem; 2009 Jul; 107(4):639-54. PubMed ID: 19479902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ERK-regulated αB-crystallin induction by matrix detachment inhibits anoikis and promotes lung metastasis in vivo.
    Malin D; Strekalova E; Petrovic V; Rajanala H; Sharma B; Ugolkov A; Gradishar WJ; Cryns VL
    Oncogene; 2015 Nov; 34(45):5626-34. PubMed ID: 25684139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrins and EGFR coordinately regulate the pro-apoptotic protein Bim to prevent anoikis.
    Reginato MJ; Mills KR; Paulus JK; Lynch DK; Sgroi DC; Debnath J; Muthuswamy SK; Brugge JS
    Nat Cell Biol; 2003 Aug; 5(8):733-40. PubMed ID: 12844146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uncovering the signaling landscape controlling breast cancer cell migration identifies novel metastasis driver genes.
    Koedoot E; Fokkelman M; Rogkoti VM; Smid M; van de Sandt I; de Bont H; Pont C; Klip JE; Wink S; Timmermans MA; Wiemer EAC; Stoilov P; Foekens JA; Le Dévédec SE; Martens JWM; van de Water B
    Nat Commun; 2019 Jul; 10(1):2983. PubMed ID: 31278301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of HtrA1 promotes resistance to anoikis and peritoneal dissemination of ovarian cancer cells.
    He X; Ota T; Liu P; Su C; Chien J; Shridhar V
    Cancer Res; 2010 Apr; 70(8):3109-18. PubMed ID: 20388781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB.
    Douma S; Van Laar T; Zevenhoven J; Meuwissen R; Van Garderen E; Peeper DS
    Nature; 2004 Aug; 430(7003):1034-9. PubMed ID: 15329723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.